BNTCBenitec Biopharma Inc
BNTC
Benitec Biopharma Inc6,356
Mkt Cap
$443.6MVolume
73,589.0052W High
$17.1552W Low
$9.70PE Ratio
-13.03BNTC Fundamentals
Price
$13.10Prev Close
$13.05Open
$13.1150D MA
$13.72Beta
0.42Avg. Volume
348,855.53EPS (Annual)
-$1.05P/B
3.67Rev/Employee
$0.00Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·3d ago
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L bought 10,215 shares of the stock in a transaction dated Thursday, December 18th. The stock was...
MarketBeat·4d ago
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 16,384 shares of the company's stock in a transaction that occurred on Friday, December...
MarketBeat·5d ago
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L acquired 10,215 shares of the stock in a transaction that occurred on Thursday, December 18th. The...
MarketBeat·5d ago
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L bought 19,542 shares of the business's stock in a transaction that occurred on Monday, December 22nd...
MarketBeat·5d ago
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of "Moderate Buy" by Brokerages
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) has earned an average rating of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat.com reports. One...
MarketBeat·12d ago
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know
The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·22d ago
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·24d ago
Franklin Resources Inc. Cuts Stake in Benitec Biopharma Limited $BNTC
Franklin Resources Inc. lowered its stake in shares of Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) by 5.6% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·29d ago
HC Wainwright Has Optimistic Outlook of BNTC FY2026 Earnings
Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Equities researchers at HC Wainwright boosted their FY2026 EPS estimates for shares of Benitec Biopharma in a research report issued to clients...
MarketBeat·1mo ago
<
1
2
...
>